Literature DB >> 23337961

[The ichthyoses. Pathophysiological models of epidermal differentiation].

D Hohl1, M Huber.   

Abstract

The ichthyoses are a heterogeneous group of monogenetically inherited disorders of cornification, and characterized clinically by scaling or hyperkeratosis. Historically, they were classified by clinical features and inheritance patterns. As a result of the recent molecular biological revolution, the ichthyoses are now recognized as comprising many diverse entities. Importantly, identical phenotypes may be caused by mutations in multiple genes, while mutations in a single gene may result in multiple and sometimes widely divergent phenotypes. The considerable complexity of this clinically and genetically heterogeneous group of disorders has prompted the need for a new classification. A classification that uses terminology based on a combination of the clinical and molecular genetic details, for instance loricrin keratoderma, is desirable. In this chapter we will use in principle the nosology adopted recently by an international group of experts at the First Ichthyosis Consensus Conference in Sorèz, France.

Entities:  

Mesh:

Year:  2013        PMID: 23337961     DOI: 10.1007/s00105-012-2407-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Clinical features of autosomal dominant and sex-linked ichthyosis in an English population.

Authors:  R S Wells; C B Kerr
Journal:  Br Med J       Date:  1966-04-16

2.  Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis.

Authors:  Alan D Irvine; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

3.  [On the ultrastructure and histochemistry of granular degeneration in vesicular ichthyosiform congenital erythrodermia].

Authors:  E R Weibel; U W Schnyder
Journal:  Arch Klin Exp Dermatol       Date:  1966

4.  Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity.

Authors:  E Petit; M Huber; A Rochat; C Bodemer; D Teillac-Hamel; J P Müh; J Revuz; Y Barrandon; M Lathrop; Y de Prost; D Hohl; A Hovnanian
Journal:  Eur J Hum Genet       Date:  1997 Jul-Aug       Impact factor: 4.246

5.  Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1.

Authors:  Florence Jobard; Caroline Lefèvre; Aysen Karaduman; Claudine Blanchet-Bardon; Serap Emre; Jean Weissenbach; Meral Ozgüc; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

6.  Recessive ichthyosis congenita type IV.

Authors:  K M Niemi; K Kuokkanen; L Kanerva; J Ignatius
Journal:  Am J Dermatopathol       Date:  1993-06       Impact factor: 1.533

7.  Ichthyosis bullosa of Siemens: a unique type of epidermolytic hyperkeratosis.

Authors:  H Traupe; G Kolde; H Hamm; R Happle
Journal:  J Am Acad Dermatol       Date:  1986-06       Impact factor: 11.527

8.  Clinical heterogeneity in epidermolytic hyperkeratosis.

Authors:  J J DiGiovanna; S J Bale
Journal:  Arch Dermatol       Date:  1994-08

9.  Molecular analysis of 250 patients with autosomal recessive congenital ichthyosis: evidence for mutation hotspots in ALOXE3 and allelic heterogeneity in ALOX12B.

Authors:  Katja-Martina Eckl; Silvia de Juanes; Janine Kurtenbach; Marc Nätebus; Jenny Lugassy; Vinzenz Oji; Heiko Traupe; Marie-Luise Preil; Francisco Martínez; Josef Smolle; Avikam Harel; Peter Krieg; Eli Sprecher; Hans C Hennies
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

10.  Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis.

Authors:  J Dahlqvist; J Klar; I Hausser; I Anton-Lamprecht; M Hellström Pigg; T Gedde-Dahl; A Gånemo; A Vahlquist; N Dahl
Journal:  J Med Genet       Date:  2007-06-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.